#drug safety
15 stories
FDA abortion pill review angers GOP lawmakers
Republican senators demand the FDA release its safety review of mifepristone sooner and commit to reinstating restrictions on the drug.
Thehill · 2m
The risky boom in cut-price weight-loss drugs
Compounding pharmacies are flooding the market with cheaper versions of GLP-1 drugs, but with far less oversight than brand-name alternatives.
TIME · 3m
GLP-1 lawsuits mount as serious harms remain unclear
Thousands of patients are suing GLP-1 drugmakers over blindness and pancreatitis, but weak reporting systems make it hard to know how often the drugs cause real harm.
NPR · 2m
Eli Lilly's unapproved weight loss drug sold illegally online
Retatrutide, still in clinical trials, is being marketed and sold to Americans through unauthorized online channels.
CBS News · 1m
FDA scrutinizes testosterone use for menopause
Doctors increasingly prescribe testosterone off-label to menopausal women, but safety data remains incomplete.
ABC News · 1m
Trump's FDA pick dodges tough questions at hearing
Dr. Heidi Overton sidestepped senators on abortion pills, vaccines, and vapes during her confirmation hearing to lead the FDA.
NBC News · 2m
HHS shifts research toward human biology, away from animals
The Department of Health and Human Services is funding new methods to replace animal testing with human organoids, AI, and tissue models.
Dallas Express · 2m
Ayurveda needs science and safety to go global
India's top Ayurveda research body calls for stronger evidence and monitoring to build credibility in modern healthcare.
The Economic Times · 1m
Three drugs older adults are still overusing
New medical guidelines warn against benzodiazepines, unnecessary antibiotics, and aspirin for prevention, but old prescribing habits die hard.
PhillyVoice · 3m
Over-the-counter drugs that aren't worth buying
A consumer watchdog tested 100+ over-the-counter medicines and found most are either ineffective or risky.
Psychologies · 1m
How to safely dispose of old medications at home
Rural Coloradans lack access to drug take-back programs, so at-home disposal products offer a practical alternative.
The Conversation · 2m
India moves to centralize sterile drug oversight
A proposal would bring all sterile medicines under central licensing to address contamination risks and regulatory fragmentation.
The Economic Times · 1m
A fake weight-loss peptide put someone in hospital
An Australian patient vomited so hard on a counterfeit peptide that their oesophagus tore, and the vial held something else entirely.
the Guardian · 1m
FDA recalls at-home IV drips over toxin risk
Six lots of wellness IV vials shipped straight to people's homes were made with a contaminated ingredient that can turn deadly.
Newsweek · 1m
A rare brain risk hiding behind GLP-1 weight loss
Fifteen cases of a vitamin B1 brain disorder turned up in people on Ozempic, Wegovy, Mounjaro and Zepbound.
Fox News · 1m